In summary, the current study, despite its post-hoc pooled design potentially introducing selection bias, suggests that adjunctive TPE therapy in septic shock is associated with a significant removal of both TF and TFPI, which may contribute to the early hemodynamic improvement observed in septic shock patients. The gene discussed is TF; the disease is septic shock.